AprilBio Co.,Ltd. (KOSDAQ:397030)

Market Cap	561.93B +8.5%
Revenue (ttm)	725.35M -97.6%
Net Income	-10.12B
EPS	-444.25
Shares Out	23.41M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	86,346
Open	25,850
Previous Close	26,450
Day's Range	25,000 - 26,800
52-Week Range	19,310 - 76,700
Beta	1.53
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About AprilBio

AprilBio Co.,Ltd. develops long-acting type biobetter and antibody biologics. The company develops antibody drugs, double antibodies, long-acting antibody drugs, long-acting protein drugs, and ADC-applied antibodies. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2013
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 397030

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 20, 2026

Data Sources Report a data error